Genetic mutations in the telomerase reverse transcriptase (TERT) gene and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene are prevalent in bladder cancer. This evidence concerns the gene TERT and urinary bladder cancer.